SEC Form 4 · accession 0001104659-15-020426
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John McDonough
Officer — President & CEO · Director
Period of report
Feb 13, 2015
Accepted (ET)
Mar 17, 2015 · 3:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.95 | Feb 13, 2015 | A | 134,124 | A | — | Feb 12, 2025 | Common Stock | 134,124 | 134,124 | D |
Explanation of responses
- F1The stock option vests in 48 equal monthly installments commencing February 13, 2015.